Population-based studies set up in several European countries on samples of cases representative of the whole cancer incidence population covered by cancer registration, collecting more detailed data than those available in the routine cancer registry activity, such as stage at diagnosis, diagnostic procedures and main treatments, in order to explain the reasons of cancer outcomes differences evident across Europe, and to identify actions needed to reduce disparities.
With the HR studies, cohorts of European cancer patient have been set up, to be prospectively followed-up to investigate the influence of pattern of patients and tunour characteristics and patterns of care on long term outcomes.
Read more ›